Logos, wordmarks, colour tokens, and the lines we'd like quoted in your story. Use anything here under MIT for AURORA proper or CC BY-SA 4.0 for the brand assets — credit AURORA, link the original, don't co-brand without writing first.
The framings below are accurate and self-contained. Use them verbatim or as anchors; please don't compress AURORA into 'AI for neurosurgery' — it is not, and that phrase will land wrong.
AURORA is an open, federated infrastructure for neurosurgical disease — from molecular origin to lifelong outcomes — co-designed with twelve pilot programmes across four continents.
It is not a medical device. It is not a product. It is the substrate that every clinical AI project currently rebuilds, released once, under MIT, with an audited path through governance.
The pilot is intentionally small. Public alpha opens in Q4 2026.
The spectrum is used sparingly — never as a background, only as accent. Long surfaces stay neutral (text on white, or text on near-black in dark mode). Reach for the spectrum when you mean to.
AURORA is an open, federated infrastructure for neurosurgical disease — from molecular origin to lifelong outcomes. Eight pilot modules cover glioma, spina bifida, tethered cord, hydrocephalus, Dandy-Walker, encephalocele, arachnoid cysts and craniosynostosis. The platform is governed by a public council with two permanent patient-advocate seats, and ships under MIT at public alpha in Q4 2026. AURORA is a public good, not a product.